Medicare and Medicaid Call Obesity a Disease: Will New GLP‑1 Rules Really Expand Access?
Medicare’s strict rules on obesity medications spark controversy. Will proposed changes finally grant access to life-changing treatments? The outcome is uncertain.
Stop Costly Scams: Ways Seniors Can Outsmart Growing Fraud Schemes
Seniors are prime targets for scams—don’t fall victim! Learn how to outsmart fraud schemes and protect your hard-earned savings. Your safety depends on it.
Walmart’s bold Medicare initiative offers seniors affordable access to GLP-1 weight-loss drugs, but will it truly change the game for obesity treatment?
